
TEMPORARILY UNAVAILABLE - GO TO UNAPPROVED PRODUCTS INJ171
Each vial contains acetazolamide sodium lyophilised powder equivalent to 500mg acetazolamide.
Glaumox is indicated for the adjunctive treatment of: oedema due to congestive heart failure; drug-induced oedema; centrencephalic epilepsies (petit mal, unlocalised seizures); chronic simple (open-angle) glaucoma; secondary glaucoma; and preoperatively in acute angle-closure glaucoma where delay of surgery is desired in order to lower intraocular pressure.
Strength500mg lyophilised powder for injection |
Package10mL vial |
Pack Size5 vials |
Phebra CodeINJ113 |
Please log in to place an order
Product Information
Consumer Medicine Information
Material Safety Data Sheet
